logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Sandra Robrecht

University of Cologne
H指数:30
被引数:3,793

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ibrutinib in early stage CLL: Genetic risk factors and treatment outcome in the GCLLSG CLL12 trial

伊布替尼在早期CLL中的应用：GCLLSG CLL12试验中的遗传风险因素和治疗结果

Blood
IF23.1
2026-06-220
OA
Armin Riecke; Sandra Robrecht; Deyan Y. Yosifov; Christof Schneider; Adam Giza; Lothar Müller; Ursula Vehling-Kaiser; Michael Eckart; Werner Freier; Björn Schöttker; Tobias Gaska; Marcel Reiser; Anna Fink; Kirsten Fischer; Barbara Eichhorst; Michael Hallek; Petra Langerbeins; Stephan Stilgenbauer; Eugen Tausch
Time-limited venetoclax combinations in untreated chronic lymphocytic leukemia: Five-year results and patient-reported outcome analysis of the randomized phase 3 CLL13/GAIA trial

限时Venetoclax联合疗法在初治慢性淋巴细胞白血病中的应用：CLL13/GAIA随机III期试验的五年结果及患者报告结局分析

Blood
IF23.1
2026-04-010
PRE
Moritz Fürstenau; Carsten U. Niemann; Sandra Robrecht; Emelie C. Rotbain; Laura Eurelings; Adam Giza; Julia von Tresckow; Can Zhang; Michael Gregor; Patrick Thornton; Philipp B. Staber; Tamar Tadmor; Vesa Lindström; Gunnar Juliusson; Ann Janssens; Caspar da Cunha-Bang; Christof Schneider; Yair Herishanu; Derville O’Shea; Michael Baumann
The Landscape and Evolution of Clonal Hematopoiesis in Chronic Lymphocytic Leukemia

克隆性造血在慢性淋巴细胞白血病中的景观与演变

Blood
IF23.1
2025-12-260
OAAI
Othman Al-Sawaf; Benjamin N. Locher; Friederike Christen; Raphael Hablesreiter; Anantharamanan Rajamani; Sandra Robrecht; Can Zhang; Anna Maria Fink; Eugen Tausch; Christof Schneider; Matthias Ritgen; Karl Anton Kreuzer; Klara Kopp; Marie-Elisa Mertz; Coral Fustero-Torre; Karsten Kleo; John F. Seymour; Piers Blombery; Lars Bullinger; Brenda Chyla
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia

Al-Sawaf, O.; Stumpf, J.; Zhang, C.; Simon, F.; Bosch, F.; Feyzi, E.; Ghia, P.; Gregor, M.; Kater, A.P.; Lindström, V.; 等. 固定疗程与持续治疗在慢性淋巴细胞白血病中的应用比较. N. Engl. J. Med. 2025, 393, 24. [Google Scholar] [CrossRef]

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2025-12-018
PRE
Al-Sawaf, Othman; Stumpf, Janina; Zhang, Can; Simon, Florian; Bosch, Francesc; Feyzi, Emadoldin; Ghia, Paolo; Gregor, Michael; Kater, Arnon P.; Lindstrom, Vesa; Mattsson, Mattias; Niemann, Carsten U.; Staber, Philipp B.; Tadmor, Tamar; Thornton, Patrick; Wendtner, Clemens-Martin; Janssens, Ann; Noesslinger, Thomas; Bohn, Jan-Paul; da Cunha-Bang, Caspar; Poulsen, Christian B.; Ranti, Juha; Illmer, Thomas; Schoettker, Bjoern; Boettcher, Sebastian; Gaska, Tobias; Vandenberghe, Elisabeth; Clifford, Ruth; Benjamini, Ohad; Frustaci, Anna Maria; Scarfo, Lydia; Sportoletti, Paolo; Schreurs, John; Levin, Mark-David; van der Straaten, Hanneke; van der Klift, Marjolein; Tran, Hoa; de la Serna, Javier; Loscertales, Javier; Lindblad, Oscar; Sandstedt, Anna Bergendahl; Goede, Jeroen; Baumann, Michael; Fink, Anna Maria; Fischer, Kirsten; Ritgen, Matthias; Kreuzer, Karl-Anton; Schneider, Christof; Tausch, Eugen; Stilgenbauer, Stephan; Robrecht, Sandra; Eichhorst, Barbara; Hallek, Michael
Acalabrutinib treatment for older (≥80 years old) and/or frail patients with CLL: primary end point analysis of the CLL-Frail trial

Acalabrutinib治疗≥80岁及/或虚弱慢性淋巴细胞白血病患者：CLL-Frail试验主要终点分析

Blood
IF23.1
2025-09-080
OAAI
Florian Simon; Rudy Ligtvoet; Jan-Paul Bohn; Thomas Nösslinger; Julia von Tresckow; Rüdiger Liersch; Tobias Gaska; Kathleen Jentsch-Ullrich; Michael Gärtner; Thomas Wolff; Ingo Schwaner; Dominik Wolf; Christof Schneider; Ursula Vehling-Kaiser; Matthias Ritgen; Christian Spoer; Michael Eckart; Thomas Decker; Geothy Chakupurukal; Björn Schöttker; Jens Kisro; Karl-Anton Kreuzer; Eugen Tausch; Stephan Stilgenbauer; Sandra Robrecht; Janina Stumpf; Anna-Maria Fink; Moritz Fürstenau; Kirsten Fischer; Valentin Goede; Michael Hallek; Barbara Eichhorst
The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL

维奈克拉-obinutuzumab在CLL中，体能和剂量强度对临床结局的影响

Blood
IF23.1
2025-08-290
OAAI
Othman Al-Sawaf; Moritz Fürstenau; Adam Giza; Sandra Robrecht; Julia von Tresckow; Anna-Maria Fink; Florian Simon; Eugen Tausch; Christof Schneider; Liliya Sivcheva; Anthony Schwarer; Javier Loscertales; Robert Weinkove; Dirk Strumberg; Allanah Kilfoyle; Gunnar Juliusson; Caspar da Cunha-Bang; Thomas Illmer; Michael Gregor; Patrick Thornton
The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL

维奈克拉-奥比妥珠单抗在CLL中，体能和剂量强度对临床结局的影响

Blood
IF23.1
2025-08-290
OAAI
Othman Al-Sawaf; Moritz Fürstenau; Adam Giza; Sandra Robrecht; Julia von Tresckow; Anna-Maria Fink; Florian Simon; Eugen Tausch; Christof Schneider; Liliya Sivcheva; Anthony Schwarer; Javier Loscertales; Robert Weinkove; Dirk Strumberg; Allanah Kilfoyle; Gunnar Juliusson; Caspar da Cunha-Bang; Thomas Illmer; Michael Gregor; Patrick Thornton
MRD-guided zanubrutinib, venetoclax, and obinutuzumab in relapsed CLL: primary end point analysis from the CLL2-BZAG trial

MRD指导下的zanubrutinib、venetoclax和obinutuzumab在复发性CLL中的应用：CLL2-BZAG试验的主要终点分析

BLOOD
IF23.1
2025-01-301
PRE
Fuerstenau, Moritz; Robrecht, Sandra; Schneider, Christof; Tausch, Eugen; Giza, Adam; Ritgen, Matthias; Bittenbring, Joerg; Hebart, Holger; Schoettker, Bjoern; Illert, Anna Lena; Graeven, Ullrich; Stoltefuss, Andrea; Heinrich, Bernhard; Eckert, Robert; Fink, Anna; Stumpf, Janina; Fischer, Kirsten; Al-Sawaf, Othman; Simon, Florian; Kleinert, Fanni; Weiss, Jonathan; Kreuzer, Karl-Anton; Schilhabel, Anke; Brueggemann, Monika; Langerbeins, Petra; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael; Cramer, Paula
Clonal Hematopoiesis in Patients with Chronic Lymphocytic Leukemia Treated with Fixed-Duration Venetoclax-Obinutuzumab or Chlorambucil-Obinutuzumab: Insights from the Randomized CLL14 Trial

慢性淋巴细胞白血病患者中接受固定疗程Venetoclax-Obinutuzumab或Chlorambucil-Obinutuzumab治疗时的克隆性造血：来自随机CLL14试验的见解

BLOOD
IF23.1
2024-11-050
PRE
Al-Sawaf, Othman; Locher, Benjamin N.; Christen, Friederike; Robrecht, Sandra; Zhang, Can; Fink, Anna Maria; Tausch, Eugen; Schneider, Christof; Ritgen, Matthias; Kreuzer, Karl Anton; Fustero, Coral; Hablesreiter, Raphael; Seymour, John F.; Blombery, Piers; Bullinger, Lars; Chyla, Brenda; Jin, Hyun Yong; Jiang, Yanwen; Stilgenbauer, Stephan; Eichhorst, Barbara F.; Hallek, Michael J.; Fischer, Kirsten; Damm, Frederik
The role of trephine bone marrow biopsies in the era of measurable residual disease-Results from the CLL10 trial of the German CLL Study Group (GCLLSG)
HEMASPHERE
IF14.6
2024-07-240
OAAI
Kutsch, Nadine; Robrecht, Sandra; Fink, Anna; Lange, Elisabeth; Weide, Rudolf; Kiehl, Michael G.; Soekler, Martin; Schlag, Rudolf; Vehling-Kaiser, Ursula; Koechling, Georg; Ploeger, Christoph; Gregor, Michael; Plesner, Torben; Clausen, Michael R.; Oschlies, Ilske; Ritgen, Matthias; Herling, Marco; Fischer, Kirsten; Doehner, Hartmut; Wendtner, Clemens-Martin; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Hallek, Michael; Boettcher, Sebastian; Klapper, Wolfram; Eichhorst, Barbara
Bendamustine, followed by obinutuzumab and idelalisib in chronic lymphocytic leukemia (CLL2-BCG): Final analysis of a multicenter, open-label phase-II-trial
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2024-04-050
OAAI
Cramer, Paula; von Tresckow, Julia; Fink, Anna-Maria; Robrecht, Sandra; Giza, Adam; Tausch, Eugen; Mueller, Lothar; Knauf, Wolfgang; Zingerle, Matthias; Al-Sawaf, Othman; Langerbeins, Petra; Fischer, Kirsten; Kreuzer, Karl-Anton; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael
Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial
NATURE MEDICINE
IF50
2023-12-0914
OAAI
Al-Sawaf, Othman; Ligtvoet, Rudy; Robrecht, Sandra; Stumpf, Janina; Fink, Anna-Maria; Tausch, Eugen; Schneider, Christof; Boettcher, Sebastian; Mikusko, Martin; Ritgen, Matthias; Schetelig, Johannes; von Tresckow, Julia; Vehling-Kaiser, Ursula; Gaska, Tobias; Wendtner, Clemens Martin; Chapuy, Bjoern; Fischer, Kirsten; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Staber, Philipp; Niemann, Carsten; Hallek, Michael; Eichhorst, Barbara
Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia (vol 14, 2147, 2023)
NATURE COMMUNICATIONS
IF15.7
2023-10-232
OAAI
Al-Sawaf, Othman; Zhang, Can; Jin, Hyun Yong; Robrecht, Sandra; Choi, Yoonha; Balasubramanian, Sandhya; Kotak, Alex; Chang, Yi Meng; Fink, Anna Maria; Tausch, Eugen; Schneider, Christof; Ritgen, Matthias; Kreuzer, Karl-Anton; Chyla, Brenda; Paulson, Joseph N.; Pallasch, Christian P.; Frenzel, Lukas P.; Peifer, Martin; Eichhorst, Barbara; Stilgenbauer, Stephan; Jiang, Yanwen; Hallek, Michael; Fischer, Kirsten
Treatment with idelalisib in patients with chronic lymphocytic leukemia - real world data from the registry of the German CLL Study Group

慢性淋巴细胞白血病患者的idelalisib治疗-来自德国CLL研究组注册表的真实数据

ANNALS OF HEMATOLOGY
IF2.4
2023-06-265
OAAI
von Tresckow, Julia; Heyl, Nikola; Robrecht, Sandra; Giza, Adam; Aldaoud, Ali; Schlag, Rudolf; Klausmann, Martine; Linde, Hartmut; Stein, Wolfgang; Schwarzer, Andreas; Fischer, Kirsten; Cramer, Paula; Eichhorst, Barbara; Hallek, Michael; Fink, Anna Maria
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia
NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2023-05-11124
PRE
Eichhorst, Barbara; Niemann, Carsten U.; Kater, Arnon P.; Fuerstenau, Moritz; von Tresckow, Julia; Zhang, Can; Robrecht, Sandra; Gregor, Michael; Juliusson, Gunnar; Thornton, Patrick; Staber, Philipp B.; Tadmor, Tamar; Lindstrom, Vesa; da Cunha-Bang, Caspar; Schneider, Christof; Poulsen, Christian B.; Illmer, Thomas; Schoettker, Bjoern; Noesslinger, Thomas; Janssens, Ann; Christiansen, Ilse; Baumann, Michael; Frederiksen, Henrik; van der Klift, Marjolein; Jaeger, Ulrich; Leys, Maria B. L.; Hoogendoorn, Mels; Lotfi, Kourosh; Hebart, Holger; Gaska, Tobias; Koene, Harry; Enggaard, Lisbeth; Goede, Jereon; Regelink, Josien C.; Widmer, Anouk; Simon, Florian; De Silva, Nisha; Fink, Anna-Maria; Bahlo, Jasmin; Fischer, Kirsten; Wendtner, Clemens-Martin; Kreuzer, Karl A.; Ritgen, Matthias; Brueggemann, Monika; Tausch, Eugen; Levin, Mark-David; van Oers, Marinus; Geisler, Christian; Stilgenbauer, Stephan; Hallek, Michael
Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia
NATURE COMMUNICATIONS
IF15.7
2023-04-1845
OAAI
Al-Sawaf, Othman; Zhang, Can; Jin, Hyun Yong; Robrecht, Sandra; Choi, Yoonha; Balasubramanian, Sandhya; Kotak, Alex; Chang, Yi Meng; Fink, Anna Maria; Tausch, Eugen; Schneider, Christof; Ritgen, Matthias; Kreuzer, Karl-Anton; Chyla, Brenda; Paulson, Joe; Pallasch, Christian P.; Frenzel, Lukas P.; Peifer, Martin; Eichhorst, Barbara; Stilgenbauer, Stephan; Jiang, Yanwen; Hallek, Michael; Fischer, Kirsten
Obinutuzumab, acalabrutinib, and venetoclax, after an optional debulking with bendamustine in relapsed or refractory chronic lymphocytic leukaemia (CLL2-BAAG) a multicentre, open-label, phase 2 trial
LANCET HAEMATOLOGY
IF17.7
2022-10-019
PRE
Cramer, Paula; Furstenau, Moritz; Robrecht, Sandra; Giza, Adam; Zhang, Can; Fink, Anna-Maria; Fischer, Kirsten; Langerbeins, Petra; Al-Sawaf, Othman; Tausch, Eugen; Schneider, Christof; Schetelig, Johannes; Dreger, Peter; Bottcher, Sebastian; Kreuzer, Karl-Anton; Schilhabel, Anke; Ritgen, Matthias; Bruggemann, Monika; Kneba, Michael; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael
Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial
LEUKEMIA
IF13.4
2022-06-254
OAAI
von Tresckow, Julia; Cramer, Paula; Robrecht, Sandra; Langerbeins, Petra; Fink, Anna-Maria; Al-Sawaf, Othman; Fuerstenau, Moritz; Illmer, Thomas; Klaproth, Holger; Tausch, Eugen; Ritgen, Matthias; Fischer, Kirsten; Wendtner, Clemens-Martin; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Boettcher, Sebastian; Eichhorst, Barbara F.; Hallek, Michael

研究方向

暂未获取到该数据
M
Michael Hallek
H 指数:124论文数:1,647被引数:7.1万
K
Kirsten Fischer
H 指数:48论文数:389被引数:1.5万
S
Stephan Stilgenbauer
H 指数:126论文数:1,220被引数:7.3万
B
Barbara Eichhorst
H 指数:62论文数:438被引数:2.1万
E
Eugen Tausch
H 指数:40论文数:315被引数:8,765
O
Othman Al‐Sawaf
H 指数:34论文数:184被引数:6,421
J
Jasmin Bahlo
H 指数:38论文数:177被引数:7,838
C
Christof Schneider
H 指数:34论文数:172被引数:4,936
J
Julia von Tresckow
H 指数:20论文数:104被引数:2,778
C
Clemens‐Martin Wendtner
H 指数:65论文数:436被引数:2.6万